Latest PILA PHARMA News & Updates

See the latest news and media coverage for PILA PHARMA. We track all announcements, press releases, and industry mentions in real time, all in one place.

PILA PHARMA

Clinical-stage biotech developing oral TRPV1 therapies for obesity and diabetes

pilapharma.com

Headquarters: Malmö, Sweden
Founded year: 2014
Company type: Public company
Number of employees: 4–10
Industry: Biotechnology & Medical Research

Last updated September 2

Latest news about PILA PHARMA

In short: PILA PHARMA dosed first subjects in its PP-CT04 obesity trial after receiving EMA approval.

Company announcements

September 2 PILA PHARMA

PILA PHARMA publishes H1 report and interview recordings online

CEO Gustav Gram discusses regulatory approval for obesity trials with Infront, Finwire, BioStock, and ProInvestor.

August 27 PILA PHARMA

PILA PHARMA reports interim financial results for H1 2026

The company received regulatory approval for a new obesity trial. Financials show operating losses and increased cash burn compared to the previous year.

April 21 PILA PHARMA

PILA PHARMA publishes its 2025 annual report highlighting obesity drug progress

The company discusses clinical trial plans for XEN-D0501 and details a successful rights issue that raised SEK 29.9 million.

April 16 PILA PHARMA

PILA PHARMA explains low exposure in rat studies

Low XEN-D0501 bioavailability masked efficacy. The company continues clinical trials using their proper formulation.

Media coverage

March 21 Placera

Pila Pharma postpones annual report and AGM (update) | Placera.se

Following inquiries from shareholders, Pila Pharma clarifies that the postponement is not linked to the company's financial position or any complications in the audit process.

March 7 Placera

PILA PHARMA: TO2 WARRANTS CONVERTED, SHARES ARE NOW TRADABLE - CEO & FOUNDER'S PARTICIPATION DISCLOSED | Placera.se

PILA PHARMA: TO2 WARRANTS CONVERTED, SHARES ARE NOW TRADABLE - CEO & FOUNDER'S PARTICIPATION DISCLOSED...

August 27, 2025 Investing.com

Pila Pharma AB (PILA) Earnings Dates & Reports

On this page, you can find detailed information about the financial performance of Pila Pharma AB, including the latest Pila Pharma AB earnings report and...

December 31, 2024 Dagens industri

Pila Pharma gör företrädesemission

Teckningskurs är fastställd till 1,50 kronor. Aktien stängde på 1,64 kronor på tisdagen. Pila Pharma släppte också delårsrapport på morgonen där rörelseresultatet för det tredje...

Never miss news about PILA PHARMA

Track PILA PHARMA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

PILA PHARMA competitors & trending companies

Browse news for competitors to PILA PHARMA and other trending companies.